ADGRA1
geneOn this page
Also known as KIAA1828
Summary
ADGRA1 (adhesion G protein-coupled receptor A1, HGNC:13838) is a protein-coding gene on chromosome 10q26.3, encoding Adhesion G protein-coupled receptor A1 (Q86SQ6). Orphan receptor.
This gene encodes a protein that belongs to the adhesion family of G-protein-coupled receptors. Members of this family function in several sensory systems and regulate blood pressure, immune responses, food intake and development. A similar protein in rodents is thought to play a role in in the regulation of neuronal signaling pathways. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.
Source: NCBI Gene 84435 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 124 total — 1 pathogenic
- Druggable target: yes
- MANE Select transcript:
NM_001083909
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13838 |
| Approved symbol | ADGRA1 |
| Name | adhesion G protein-coupled receptor A1 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1828 |
| Ensembl gene | ENSG00000197177 |
| Ensembl biotype | protein_coding |
| OMIM | 612302 |
| Entrez | 84435 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000392606, ENST00000392607, ENST00000864054
RefSeq mRNA: 2 — MANE Select: NM_001083909
NM_001083909, NM_001291085
CCDS: CCDS41580, CCDS76362
Canonical transcript exons
ENST00000392607 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001512487 | 133087924 | 133088138 |
| ENSE00001622464 | 133096974 | 133097101 |
| ENSE00001680963 | 133098640 | 133098763 |
| ENSE00001931650 | 133128329 | 133131675 |
| ENSE00002209139 | 133088708 | 133088912 |
| ENSE00002494549 | 133127233 | 133127331 |
| ENSE00003514083 | 133102697 | 133102842 |
Expression profiles
Bgee: expression breadth broad, 94 present calls, max score 87.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8990 / max 41.5640, expressed in 168 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107745 | 0.6984 | 150 |
| 107746 | 0.1045 | 56 |
| 107747 | 0.0389 | 25 |
| 107744 | 0.0339 | 21 |
| 107743 | 0.0234 | 11 |
Top tissues by expression
221 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right frontal lobe | UBERON:0002810 | 87.87 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.62 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.44 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.82 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.09 | gold quality |
| hypothalamus | UBERON:0001898 | 83.70 | gold quality |
| neocortex | UBERON:0001950 | 83.37 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 83.32 | gold quality |
| frontal cortex | UBERON:0001870 | 83.18 | gold quality |
| primary visual cortex | UBERON:0002436 | 82.14 | gold quality |
| cerebral cortex | UBERON:0000956 | 81.74 | gold quality |
| amygdala | UBERON:0001876 | 80.75 | gold quality |
| ventricular zone | UBERON:0003053 | 79.32 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 79.05 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.61 | gold quality |
| Ammon’s horn | UBERON:0001954 | 77.89 | gold quality |
| forebrain | UBERON:0001890 | 76.36 | gold quality |
| occipital lobe | UBERON:0002021 | 76.18 | gold quality |
| temporal lobe | UBERON:0001871 | 76.16 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 75.52 | gold quality |
| pancreatic ductal cell | CL:0002079 | 74.87 | silver quality |
| brain | UBERON:0000955 | 74.74 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.26 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 73.26 | gold quality |
| substantia nigra | UBERON:0002038 | 72.57 | gold quality |
| spinal cord | UBERON:0002240 | 72.56 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 71.92 | gold quality |
| nucleus accumbens | UBERON:0001882 | 71.05 | gold quality |
| caudate nucleus | UBERON:0001873 | 71.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
81 targeting ADGRA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-190A-5P | 99.54 | 71.45 | 933 |
| HSA-MIR-190B-5P | 99.54 | 71.40 | 925 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4688 | 99.48 | 64.68 | 828 |
Literature-anchored findings (GeneRIF, showing 3)
- Studies indicate that the orthologs of GP123 in mouse and rat play a role in the regulation of neuronal signaling pathways. (PMID:17212699)
- Adhesion GPR123 is an indicator for recurrence and prognosis in bladder cancer. (PMID:33945147)
- Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency. (PMID:36672239)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Adgra1 | ENSMUSG00000025475 |
| rattus_norvegicus | Adgra1 | ENSRNOG00000054955 |
Paralogs (42): CALCR (ENSG00000004948), GIPR (ENSG00000010310), ADGRA2 (ENSG00000020181), CALCRL (ENSG00000064989), GLP2R (ENSG00000065325), ADGRF5 (ENSG00000069122), ADGRL1 (ENSG00000072071), ADCYAP1R1 (ENSG00000078549), SCTR (ENSG00000080293), VIPR2 (ENSG00000106018), CRHR2 (ENSG00000106113), GHRHR (ENSG00000106128), ADGRD1 (ENSG00000111452), GLP1R (ENSG00000112164), ADGRG6 (ENSG00000112414), VIPR1 (ENSG00000114812), ADGRL2 (ENSG00000117114), CRHR1 (ENSG00000120088), ADGRB2 (ENSG00000121753), ADGRE5 (ENSG00000123146), ADGRE2 (ENSG00000127507), ADGRE3 (ENSG00000131355), ADGRB3 (ENSG00000135298), PTH2R (ENSG00000144407), ADGRG7 (ENSG00000144820), ADGRL3 (ENSG00000150471), ADGRA3 (ENSG00000152990), ADGRF1 (ENSG00000153292), ADGRF4 (ENSG00000153294), ADGRG4 (ENSG00000156920), ADGRG5 (ENSG00000159618), PTH1R (ENSG00000160801), ADGRL4 (ENSG00000162618), EVA1C (ENSG00000166979), ADGRF3 (ENSG00000173567), ADGRG2 (ENSG00000173698), ADGRE1 (ENSG00000174837), ADGRD2 (ENSG00000180264), ADGRB1 (ENSG00000181790), ADGRG3 (ENSG00000182885)
Protein
Protein identifiers
Adhesion G protein-coupled receptor A1 — Q86SQ6 (reviewed: Q86SQ6)
Alternative names: G-protein coupled receptor 123
All UniProt accessions (1): Q86SQ6
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor.
Subcellular location. Membrane.
Similarity. Belongs to the G-protein coupled receptor 2 family. Adhesion G-protein coupled receptor (ADGR) subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86SQ6-3 | 3 | yes |
| Q86SQ6-1 | 1 | |
| Q86SQ6-2 | 2 |
RefSeq proteins (2): NP_001077378, NP_001278014 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000832 | GPCR_2_secretin-like | Family |
| IPR017981 | GPCR_2-like_7TM | Domain |
| IPR017983 | GPCR_2_secretin-like_CS | Conserved_site |
| IPR051963 | Adhesion_GPCR_A | Family |
Pfam: PF00002
UniProt features (30 total): topological domain 8, transmembrane region 7, region of interest 3, compositionally biased region 3, splice variant 3, sequence variant 3, chain 1, glycosylation site 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86SQ6-F1 | 64.30 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 75
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, GOCC_POSTSYNAPSE, GOCC_SYNAPSE, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOCC_GLUTAMATERGIC_SYNAPSE, GOCC_NEURON_TO_NEURON_SYNAPSE, MIR6867_5P, MIR5010_3P, MIR4731_5P, MIR6722_3P, MIR5589_3P, MIR190A_5P, MIR1909_3P
GO Biological Process (3): signal transduction (GO:0007165), cell surface receptor signaling pathway (GO:0007166), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), transmembrane signaling receptor activity (GO:0004888)
GO Cellular Component (4): plasma membrane (GO:0005886), postsynaptic density (GO:0014069), membrane (GO:0016020), glutamatergic synapse (GO:0098978)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| signaling receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| asymmetric synapse | 1 |
| postsynaptic specialization | 1 |
| cellular anatomical structure | 1 |
| synapse | 1 |
Protein interactions and networks
STRING
818 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ADGRA1 | SCTR | P47872 | 817 |
| ADGRA1 | KNDC1 | Q76NI1 | 665 |
| ADGRA1 | ADGRG5 | Q8IZF4 | 639 |
| ADGRA1 | ADGRF2P | Q8IZF7 | 615 |
| ADGRA1 | ADGRG3 | Q86Y34 | 612 |
| ADGRA1 | ADGRG7 | Q96K78 | 603 |
| ADGRA1 | ADGRD2 | Q7Z7M1 | 595 |
| ADGRA1 | ADGRF1 | Q5T601 | 584 |
| ADGRA1 | ADGRF3 | Q8IZF5 | 573 |
| ADGRA1 | ADGRF4 | Q8IZF3 | 566 |
| ADGRA1 | ADGRG1 | Q9Y653 | 559 |
| ADGRA1 | ADGRF5 | Q8IZF2 | 542 |
| ADGRA1 | GPR68 | Q15743 | 530 |
| ADGRA1 | CDH24 | Q86UP0 | 518 |
| ADGRA1 | GPR162 | Q16538 | 510 |
IntAct
125 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DLG1 | ADGRA1 | psi-mi:“MI:0915”(physical association) | 0.610 |
| ADGRA1 | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.610 |
| ADGRA1 | SNX27 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | MAGI2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | SYNJ2BP | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | PDZD7 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | PTPN3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | SCRIB | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | SNTB1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | MAGI1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | SNTA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | RHPN1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | TAX1BP3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ADGRA1 | PDZRN4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (1): GPR123 (Positive Genetic)
ESM2 similar proteins: A0A2R9YJI3, A3KFU9, A6QLU6, B2ZHY2, B4XF06, D3Z7H4, D3ZK93, D4A6L0, E1BBQ2, O43194, O75204, P51810, P70259, P82352, Q14714, Q16538, Q17QQ5, Q2T9K0, Q3UN16, Q49LS8, Q4V922, Q5E9H8, Q5MNU5, Q5T848, Q5U431, Q62147, Q6NV75, Q6PI62, Q6UXU4, Q7RTS5, Q7TQN9, Q80ZU9, Q86SQ6, Q8BGE9, Q8BGP5, Q8C419, Q8C4G9, Q8K0Z9, Q8NBV4, Q8VHW3
Diamond homologs: E7FBY6, Q7TT36, Q86SQ6, Q8C4G9, Q8IWK6, Q91ZV8, Q96PE1, S4X0Q8, P48960, Q9BY15, G5EFX6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 80 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 56.0× | 1e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 53.3× | 1e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 53.3× | 1e-06 |
| Long-term potentiation | 5 | 46.6× | 2e-06 |
| Assembly and cell surface presentation of NMDA receptors | 8 | 39.8× | 2e-09 |
| Neurexins and neuroligins | 9 | 34.8× | 6e-10 |
| Protein-protein interactions at synapses | 5 | 26.0× | 3e-05 |
| RHOA GTPase cycle | 5 | 7.3× | 5e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 10 | 75.5× | 2e-14 |
| protein localization to synapse | 6 | 59.7× | 9e-08 |
| receptor clustering | 7 | 56.7× | 7e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 38.6× | 8e-07 |
| cell-cell adhesion | 10 | 13.2× | 4e-07 |
| protein-containing complex assembly | 8 | 11.8× | 2e-05 |
| regulation of small GTPase mediated signal transduction | 5 | 9.3× | 4e-03 |
| protein localization to plasma membrane | 6 | 8.5× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 112 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3061841 | GRCh38/hg38 10q26.2-26.3(chr10:125976998-133427130)x1 | Pathogenic |
SpliceAI
1825 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:133088910:ATGG:A | donor_loss | 1.0000 |
| 10:133088911:TGGTG:T | donor_loss | 1.0000 |
| 10:133088913:G:GG | donor_gain | 1.0000 |
| 10:133088913:GTG:G | donor_loss | 1.0000 |
| 10:133097099:GAG:G | donor_gain | 1.0000 |
| 10:133097099:GAGG:G | donor_loss | 1.0000 |
| 10:133097101:GGTG:G | donor_loss | 1.0000 |
| 10:133097103:T:G | donor_loss | 1.0000 |
| 10:133098630:C:CA | acceptor_gain | 1.0000 |
| 10:133098636:ACAGC:A | acceptor_gain | 1.0000 |
| 10:133098637:C:G | acceptor_gain | 1.0000 |
| 10:133098637:CA:C | acceptor_loss | 1.0000 |
| 10:133098638:A:AC | acceptor_loss | 1.0000 |
| 10:133098638:A:AG | acceptor_gain | 1.0000 |
| 10:133098638:AGC:A | acceptor_gain | 1.0000 |
| 10:133098639:G:A | acceptor_loss | 1.0000 |
| 10:133098639:G:GA | acceptor_gain | 1.0000 |
| 10:133098639:GC:G | acceptor_gain | 1.0000 |
| 10:133098639:GCG:G | acceptor_gain | 1.0000 |
| 10:133098639:GCGC:G | acceptor_gain | 1.0000 |
| 10:133098639:GCGCC:G | acceptor_gain | 1.0000 |
| 10:133098761:GCG:G | donor_gain | 1.0000 |
| 10:133127327:GCGTA:G | donor_gain | 1.0000 |
| 10:133127329:GTA:G | donor_gain | 1.0000 |
| 10:133127332:G:GG | donor_gain | 1.0000 |
| 10:133128323:CCACA:C | acceptor_loss | 1.0000 |
| 10:133128324:CACA:C | acceptor_loss | 1.0000 |
| 10:133128326:CAGC:C | acceptor_loss | 1.0000 |
| 10:133128327:A:AG | acceptor_gain | 1.0000 |
| 10:133128327:A:AT | acceptor_loss | 1.0000 |
AlphaMissense
3616 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:133128723:G:A | G299R | 0.994 |
| 10:133128723:G:C | G299R | 0.994 |
| 10:133128756:C:A | R310S | 0.994 |
| 10:133128636:T:A | W270R | 0.992 |
| 10:133128636:T:C | W270R | 0.992 |
| 10:133097061:T:C | C31R | 0.991 |
| 10:133128757:G:C | R310P | 0.990 |
| 10:133102739:T:A | W100R | 0.989 |
| 10:133102739:T:C | W100R | 0.989 |
| 10:133128351:A:C | S175R | 0.989 |
| 10:133128353:C:A | S175R | 0.989 |
| 10:133128353:C:G | S175R | 0.989 |
| 10:133128690:A:C | S288R | 0.989 |
| 10:133128692:C:A | S288R | 0.989 |
| 10:133128692:C:G | S288R | 0.989 |
| 10:133128762:G:C | D312H | 0.989 |
| 10:133128703:G:A | G292D | 0.987 |
| 10:133128724:G:A | G299E | 0.986 |
| 10:133128763:A:C | D312A | 0.986 |
| 10:133128763:A:T | D312V | 0.985 |
| 10:133128646:G:A | G273E | 0.984 |
| 10:133127283:C:A | A151D | 0.983 |
| 10:133128702:G:C | G292R | 0.983 |
| 10:133128645:G:T | G273W | 0.982 |
| 10:133129490:G:C | W554C | 0.982 |
| 10:133129490:G:T | W554C | 0.982 |
| 10:133098716:T:C | F70L | 0.981 |
| 10:133098718:C:A | F70L | 0.981 |
| 10:133098718:C:G | F70L | 0.981 |
| 10:133128332:C:G | C168W | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000006828 (10:133107282 T>C), RS1000020339 (10:133129964 G>A,T), RS1000038962 (10:133118591 G>A,T), RS1000087381 (10:133103909 G>T), RS1000100230 (10:133114241 G>A), RS1000119936 (10:133104042 G>A,T), RS1000209338 (10:133115878 C>T), RS1000247223 (10:133095235 A>G), RS1000430373 (10:133114034 C>T), RS1000436387 (10:133100023 T>C), RS1000443095 (10:133107541 T>C), RS1000574950 (10:133112245 T>C), RS1000579786 (10:133087796 C>T), RS1000652578 (10:133108033 G>A), RS1000677929 (10:133122723 T>C)
Disease associations
OMIM: gene MIM:612302 | disease phenotypes: MIM:617330, MIM:126800
GenCC curated gene-disease
Mondo (2): hypotonia, ataxia, and delayed development syndrome (MONDO:0015021), Duane syndrome type 1 (MONDO:0024265)
Orphanet (2): Duane retraction syndrome (Orphanet:233), Developmental delay-ataxia-hypotonia-facial dysmorphism syndrome (Orphanet:658843)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003264_771 | Post bronchodilator FEV1/FVC ratio | 3.000000e-07 |
| GCST008369_14 | Plasma anti-thyroglobulin levels | 2.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004713 | FEV/FVC ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523885 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Adhesion Class GPCRs
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| Tobacco Smoke Pollution | decreases expression, decreases methylation | 2 |
| bisphenol A | decreases methylation | 1 |
| bisphenol S | decreases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, affects methylation | 1 |
| Arsenic | affects methylation | 1 |
| Vehicle Emissions | affects methylation, increases abundance | 1 |
| Nitrogen Dioxide | affects methylation, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883404 | Binding | PRESTO-Tango GPCRome screening (GPR123) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KX28 | PathHunter CHO-K1 GPR123 beta-arrestin | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Duane syndrome type 1, hypotonia, ataxia, and delayed development syndrome